How much has Ambagon Therapeutics raised?
$108.0Macross 3 recorded rounds · Jul 2020 – Jan 2025
Most recently, Ambagon Therapeutics raised $5.0M in its Early Stage VC (Jan 2025).
Free account
More of Ambagon Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Ambagon Therapeutics: the Monday email on marks, rounds and moves
Ambagon Therapeutics round by round
3 rounds4 investors participated
Jan 2022Early Stage VC (Series A)$85.0M▮
+ 1 more investors · free account
8 investors participated
How much has Ambagon Therapeutics raised?
Ambagon Therapeutics has raised $108 million across 3 recorded rounds since 2020. The largest was an $85 million Series A in Jan 2022; the most recent was a $5 million early-stage round in Jan 2025.
Ambagon Therapeutics has filed 6 Form Ds with the SEC since 2020, most recently in Feb 2025 ($5 million sold to 4 investors).
Ambagon Therapeutics investors
13 investors are on record for Ambagon Therapeutics, including RA Capital Management, Citadel Enterprise Americas, AbbVie Ventures and Blackwell Partners. The early-stage round in Jan 2025 drew 4 investors.
For fundraisers
Raising for a company like Ambagon Therapeutics?
13 investors have backed Ambagon Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Ambagon Therapeutics
- How much has Ambagon Therapeutics raised?
- Ambagon Therapeutics has raised $108.0M in total across 3 recorded funding rounds.
- When was Ambagon Therapeutics's last funding round?
- Ambagon Therapeutics's most recent recorded round was Early Stage VC in Jan 2025, raising $5.0M.